Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,061 | 290 | 79.8% |
| Consulting Fee | $1,785 | 2 | 20.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $1,591 | 24 | $0 (2024) |
| TG Therapeutics, Inc. | $1,009 | 5 | $0 (2024) |
| EMD Serono, Inc. | $959.58 | 30 | $0 (2024) |
| ABBVIE INC. | $772.94 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $560.60 | 17 | $0 (2024) |
| Biogen, Inc. | $554.50 | 16 | $0 (2024) |
| SK Life Science, Inc. | $489.31 | 15 | $0 (2024) |
| Celgene Corporation | $260.16 | 13 | $0 (2024) |
| Genentech USA, Inc. | $248.47 | 6 | $0 (2024) |
| PFIZER INC. | $240.73 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,785 | 143 | Lundbeck LLC ($1,244) |
| 2023 | $4,010 | 110 | TG Therapeutics, Inc. ($956.18) |
| 2022 | $1,052 | 39 | Biogen, Inc. ($367.30) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.08 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Genentech USA, Inc. | Enspryng (Biological), Ocrevus, Ocrevus Zunovo | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Immunology | ||||||
| 12/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $29.00 | General |
| 12/05/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: PAIN | ||||||
| 11/23/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $29.55 | General |
| Category: NEUROLOGY | ||||||
| 11/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: EPILEPSY | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: PAIN | ||||||
| 11/13/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $29.00 | General |
| 11/08/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 11/06/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neurology | ||||||
| 11/05/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Neurology | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Neurology | ||||||
About Marissa Casillo, FNP
Marissa Casillo, FNP is a Family healthcare provider based in Foxborough, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2022. The National Provider Identifier (NPI) number assigned to this provider is 1972251817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marissa Casillo, FNP has received a total of $8,846 in payments from pharmaceutical and medical device companies, with $3,785 received in 2024. These payments were reported across 292 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,061).
Practice Information
- Specialty Family
- Other Specialties Family
- Location Foxborough, MA
- Active Since 03/10/2022
- Last Updated 04/14/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1972251817
Products in Payments
- VYEPTI (Biological) $1,591
- BRIUMVI (Drug) $1,009
- MAVENCLAD (Drug) $582.06
- KESIMPTA (Drug) $560.60
- QULIPTA (Drug) $408.60
- ZEPOSIA (Drug) $260.16
- TYSABRI (Biological) $238.43
- UBRELVY (Drug) $187.74
- Hizentra (Biological) $174.86
- UPLIZNA (Biological) $159.86
- Ocrevus (Biological) $149.27
- VYVGART (Drug) $138.42
- NURTEC ODT (Drug) $136.16
- BOTOX (Biological) $133.54
- PURIFIED CORTROPHIN GEL (Drug) $106.29
- Enspryng (Biological) $99.20
- QUTENZA (Drug) $92.04
- Leqembi (Drug) $91.70
- ULTOMIRIS (Biological) $89.95
- XCOPRI (Drug) $88.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.